Why a pioneering therapy chatbot shut down

Woebot founder Alison Darcy describes regulatory struggles — and her pivot.

July 5, 2025 Check out STAT+

Sponsored By

Snag a deal on STAT+ this holiday weekend: Get 50% off an annual subscription and access award-winning journalism, subscriber-only newsletters and email alerts, premium data tools, and event discounts. Thanks for reading!

Adobe STAT+ | Why Woebot, a pioneering therapy chatbot, shut down The demise of Woebot, a therapy chatbot, shows how AI is moving faster than the ability of the FDA to regulate it, says founder Alison Darcy. By Mario Aguilar Chip Somodevilla/Getty Images STAT+ | How the tax-cut bill that's headed to Trump's desk would upend health care Trump is set to sign a bill that will make transformational changes to Medicaid and the ACA. By Daniel Payne, Chelsea Cirruzzo, and John Wilkerson Adobe STAT+ | Terminated NIH grants are being reinstated almost entirely in blue states NIH grant restoration process plays out over landscape splintered by DEI restrictions, court order that applies in the blue states that sued By Anil Oza STAT+ | Europe, with ambitions to poach American scientists, faces pressures of its own French universities are offering refuge to U.S. researchers as NIH funding faces steep cuts under Trump. Europe positions itself as a science haven. By Andrew Joseph Opinion: RFK Jr.'s intellectually dishonest excuse for defunding Gavi, the Vaccine Alliance Former CDC chief says in pulling U.S. funding for Gavi, the Vaccine Alliance, RFK Jr. used 'an inaccurate study to justify withholding lifesaving funds.' By Tom Frieden Why this activist is putting her body on the line for Americans with disabilities Latoya Maddox, an activist, on the fight to protect the needs of disabled Americans, as time runs out to save their Medicaid-funded services. By O. Rose Broderick Who is the Senate parliamentarian, and why do they matter for Medicaid? STAT's behind-the-headlines video series looks at health care upheaval in the Trump tax bill and the key role played by, of all things, the parliamentarian. By Alex Hogan STAT+ | Opinion: Lessons from Duke's nuked mega cord blood deal with Cryo-Cell A failed Duke-Cryo-Cell deal shows the need for more oversight and transparency in the cell therapy field — especially when kids are involved. By Paul Knoepfler

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser